Evaluation of CYP2C9 Activity
NCT00162461
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
1200
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Phenytoin single dose (300 mg)
Sponsor
Hadassah Medical Organization
Collaborators
[object Object]